Fig. (3).
Comparison of percentage of positive findings between Tektrotyd® and 18F- FDG based on tumor grade. Adapted from Education Exhibit presentation “Neuroendocrine Neoplasms of the Lung: Pathologic Classification and Spectrum of Molecular Imaging Findings”, RSNA Annual Meeting 2012. (A higher resolution / colour version of this figure is available in the electronic copy of the article).